Identifying the Well-suited Chinese Herbal Products for Hepatocellular Carcinoma (HCC) Patients in Terms of Hazard Ratio and Child-Pugh Score Improvement: A Frequentist Statistical Analysis Applying ‘Netmeta’

Hepatocellular carcinoma (HCC) causes high mortality and global burden. In addition to the conventional western treatments, HCC patients are actively seeking adjuvant therapies, such as traditional Chinese medicine (TCM), hoping to improve treatment outcomes and prolong survival. Until 2021, only tw...

Full description

Bibliographic Details
Main Author: Ka-Cheng Lo
Format: Article
Language:English
Published: Athens Institute for Education and Research 2022-12-01
Series:Athens Journal of Health and Medical Sciences
Subjects:
Online Access:https://www.athensjournals.gr/health/2022-9-4-3-Lo.pdf